Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Patients with Multiple Sclerosis

Abstract

There is an association between higher CV risk factors and the use of DMTs. Furthermore, CV and related drugs have the potential for modulating MS disease severity.